Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Separation or purification
Reexamination Certificate
2006-04-25
2011-11-15
Audet, Maury (Department: 1654)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Separation or purification
C530S412000, C530S328000, C530S329000
Reexamination Certificate
active
08058410
ABSTRACT:
Disclosed is an affinity matrix comprising a solid phase and an affinity ligand comprising peptide bonds coupled to this solid phase, wherein the affinity ligand comprising peptide bond is selected from the following group of ligands: a) peptides comprising the formula X1X2X3X4, wherein X1to X4are amino acid residues and at least two of X1to X4is W, Y or F; b) peptides comprising the formula X5X6X7X8, wherein X5to X8are amino acid residues, at least one of X5to X8is W, and at least one of X5to X8is E or D; and c) poly-amino acids consisting of an amino acid monomer of the group consisting of R, K, E and D and an amino acid monomer of the group consisting of Y, F and W, preferably poly-KY, poly-KF, poly-KW, poly-RY, poly-RF, poly-RW, poly-EY, poly-DY, poly-EF, poly-EW, poly-DF and poly-DW, with the proviso that the peptides according to a) and b) have a maximum length of 35 amino acid residues and that the poly-amino acids according to c) have a minimum length of 20 amino acid residues.
REFERENCES:
patent: 2003/0166240 (2003-09-01), Shrader et al.
patent: 2005/0036980 (2005-02-01), Chaney et al.
patent: 2009/0203069 (2009-08-01), Jungbauer et al.
patent: WO-94/18345 (1994-08-01), None
patent: WO-98/15572 (1998-04-01), None
patent: WO-99/14232 (1999-03-01), None
patent: WO-01/11057 (2001-02-01), None
patent: WO-02/062969 (2002-08-01), None
patent: WO-02/088171 (2002-11-01), None
patent: WO2009039854 (2009-04-01), None
Alloza I et al., “Cross-linking approach to affinity capture of protein complexes from chaotrop-solubilized cell lysates”, Analytical Biochemistry, Academic Press, vol. 324, No. 1, Jan. 1, 2004, pp. 137-142.
Database NCBI [Online] 2001, Davoodi-Semiromi A et al.: “Direct submission” XP002397791, retrieved from NCBI, Database accession No. AAL05891, abstract.
Database NCBI [Online] 1999, Hongyuan J & Meiyun Z: “Direct submission” XP002397792, retrieved from NCBI, Database accession No. AAD56386, abstract.
Liu, Ruiwu et al., “Cmbinatorial peptide library methods for immunobiology research”, Experimental Hermatology, 2003, vol. 31, pp. 11-30.
Buettner, Joseph A. et al., “Chemically derived peptide libraries: A new resin and methodology for lead identification”, Int. J. Peptide Protein Res., 1996, vol. 47, pp. 70- 83.
Alloza I et al., Analytical Biochemistry, Academic Press, vol. 324, No. 1, Jan. 1, 2004, pp. 137-142.
Davoodi-Semiromi A et al., Diabetes, vol. 51, No. 7, 2002, pp. 2334-2336., Isr.
Achmüller Clemens
Auer Bernhard
Hahn Rainer
Jungbauer Alois
Kaar Waltraud
Audet Maury
Birch & Stewart Kolasch & Birch, LLP
Boehringer Ingelheim RCV GmbH & Co KG
Sandoz AG
LandOfFree
Affinity ligands does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Affinity ligands, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Affinity ligands will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4288650